Clinical and angiographic results of dilatation procedures for symptomatic intracranial atherosclerotic disease

Journal of Neuroimaging

Volumn 15, Issue 3, 2005, Pages 240-249

  Qureshi, Adnan I ^a,b,c   Suri, M Fareed K ^a   Siddiqui, Amir M ^b   Kim, Stanley H ^a   Boulos, Alan S ^a   Ringer, Andrew J ^a   Lopes, Demetrius K ^a   Guterman, Lee R ^a   Hopkins, L Nelson ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Angioplasty; Intracranial atherosclerosis; Intracranial stenosis; Ischemic stroke; Stent

Indexed keywords

ADULT; AGED; ANGIOPLASTY; ARTERY DILATATION; ARTERY OCCLUSION; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEUROIMAGING; RESTENOSIS; STENT; STROKE; SURVIVAL; TREATMENT OUTCOME;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ANGIOPLASTY, BALLOON; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; DILATATION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; STENTS; TIME FACTORS;

EID: 20844457954     PISSN: 10512284     EISSN: None     Source Type: Journal    
DOI: 10.1177/1051228405277343     Document Type: Article

References (37)

1. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995;26:14-20.
2. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996;27:1974-1980.
3. Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W. Atherosclerotic disease of the middle cerebral artery. Stroke 1986;17:1112-1120.
4. Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995;45:1488-1493.
5. Chimowitz M, Lynn M, Howlett-Smith H, et al, for the WASID investigators. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial. Stroke 2004;35:235.
6. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490-498.
7. Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988;11:1-11.
8. Lang TA, Secic M, eds. Assessing time-to-an-event as an endpoint: reporting survival analysis. In: How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors and Reviewers. Philadelphia, PA: American College of Physicians; 1997:137-146.
9. Akins PT, Pilgram TK, Cross DT III, Moran CJ. Natural history of stenosis from intracranial atherosclerosis by serial, angiography. Stroke 1998;29:433-438.
10. Callahan AS III, Berger BL. Balloon angioplasty of intracranial arteries for stroke prevention. J Neuroimaging 1997;7:232-235.
11. Clark WM, Barnwell SL, Nesbit G, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 1995;26:1200-1204.
12. Connors JJ III, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neuroimaging 1999;91:415-423.
13. Higashida RT, Tsai FY, Halbach VV, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. AJNR Am J Neuroradiol 1993;78:192-198.
14. Kellogg JX, Nesbit GM, Clark WM, Barnwell SL. The role of angioplasty in the treatment of cerebrovascular disease. Neurosurgery 1998;43:549-555.
15. Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999;30:1065-1069.
16. Mori T, Mori K, Fukuoka M, Arisawa M, Honda S. Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiology 1997;39:111-116.
17. Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 1997;18:1661-1668.
18. Terada T, Higashida RT, Halbach W, et al. Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries. J Neurol Neurosurg Psychiatr 1996;60:377-381.
19. Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998;19:1525-1533.
20. Nahser HC, Henkes H, Weber W, Berg-Dammer E, Yousry TA, Kuhne D. Intracranial vertebrobasilar stenosis: angioplasty and follow-up. AJNR Am J Neuroradiol 2000;21:1293-1301.
21. Al-Mubarak N, Gomez CR, Vitek JJ, Roubin GS. Stenting of symptomatic stenosis of the intracranial internal carotid artery. AJNR Am J Neuroradiol 1998;19:1949-1951.
22. Feldman RL, Trigg L, Gaudier J, Galat J. Use of coronary Palmaz-Schatz stent in the percutaneous treatment of an intracranial carotid artery stenosis. Cathet Cardiovasc Diagn 1996;38:316-319.
23. Gomez CR, Misra VK, Campbell MS, Soto RD. Elective stenting of symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 2000;21:971-973.
24. Gomez CR, Misra VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31:95-99.
25. Horowitz MB, Pride GL, Graybeal DF, Purdy PD. Percutaneous transluminal angioplasty and stenting of midbasilar stenoses: three technical case reports and literature review. Neurosurgery 1999;45:925-930.
26. Joseph GJ, Goldstein J, Cloft H, Tong F, Dion J. Endovascular stenting of atherosclerotic stenosis in a basilar artery after unsuccessful angioplasty. AJR Am J Roentgenol 2000;174:383-385.
27. Lanzino G, Fessler RD, Miletich RS, Guterman LR, Hopkins LN. Angioplasty and stenting of basilar artery stenosis: technical case report. Neurosurgery 1999;45:404-407.
28. Mori T, Kazita K, Chokyu K, Mima T, Mori K. Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 2000;21:249-254.
29. Morris PP, Martin EM, Regan J, Braden G. Intracranial deployment of coronary stents for symptomatic atherosclerotic disease. AJNR Am J Neuroradiol 1999;20:1688-1694.
30. Phatouros CC, Lefler JE, Higashida RT, et al. Primary stenting for high-grade basilar artery stenosis. AJNR Am J Neuroradiol 2000;21:1744-1749.
31. SSYLVIA Study Investigators. Lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke 2004;35:1388-1392.
32. Buller CE, Dzavik V, Carere RG, et al. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation 1999;100:236-242.
33. Macaya C, Serruys PW, Ruygrok P, et al. Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group. J Am Coll Cardiol 1996;27:255-261.
34. Higashida RT, Hieshima GB, Tsai FY, Halbach W, Norman D, Newton TH. Transluminal angioplasty of the vertebral and basilar arteries. AJNR Am J Neuroradiol 1987;8:745-749.
35. O'Meara JJ, Dehmer GJ. Care of the patient and management of complications after percutaneous coronary artery interventions. Ann Intern Med 1997;127:458-471.
36. Holmes DR Jr, Vlietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984;53:77C-81C.
37. Garas SM, Huber P, Scott NA. Overview of therapies for prevention of restenosis after coronary interventions. Pharmacol Ther 2001;92:165-178.